Gene · 5588
Papers1,848
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,848
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of a Competing Endogenous RNA Co-Expression Network in Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2023 | 37955025 | PubTator, text mining | PubMed |
| Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors. | Heliyon | 2023 | 37954355 | PubTator, text mining | PubMed |
| TCR Pathway Mutations in Mature T Cell Lymphomas. | J Immunol | 2023 | 37931208 | PubTator, text mining | PubMed |
| Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer. | Clin Transl Med | 2023 | 37877353 | PubTator, text mining | PubMed |
| Metabolic regulation of forkhead box P3 alternative splicing isoforms and their impact on health and disease. | Front Immunol | 2023 | 37868998 | PubTator, text mining | PubMed |
| Bringing cell therapy to tumors: considerations for optimal CAR binder design. | Antib Ther | 2023 | 37846297 | PubTator, text mining | PubMed |
| Glutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targets. | Heliyon | 2023 | 37829798 | PubTator, text mining | PubMed |
| A pharmacophore-guided deep learning approach for bioactive molecular generation. | Nat Commun | 2023 | 37803000 | PubTator, text mining | PubMed |
| Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. | Immunotargets Ther | 2023 | 37795196 | PubTator, text mining | PubMed |
| Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides. | Front Immunol | 2023 | 37790936 | PubTator, text mining | PubMed |
| The long non-coding RNA LINC00707 interacts with Smad proteins to regulate TGFβ signaling and cancer cell invasion. | Cell Commun Signal | 2023 | 37784093 | PubTator, text mining | PubMed |
| Artificial sweetener sucralose: a possible modulator of autoimmune diseases. | Signal Transduct Target Ther | 2023 | 37779177 | PubTator, text mining | PubMed |
| Significance of platelet adhesion-related genes in colon cancer based on non-negative matrix factorization-based clustering algorithm. | Digit Health | 2023 | 37766908 | PubTator, text mining | PubMed |
| Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting. | Cancers (Basel) | 2023 | 37760447 | PubTator, text mining | PubMed |
| Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors. | Stem Cell Rev Rep | 2023 | 37755647 | PubTator, text mining | PubMed |
| Identification and experimental validation of autophagy-related genes in abdominal aortic aneurysm. | Eur J Med Res | 2023 | 37737183 | PubTator, text mining | PubMed |
| Identification of a TRP channel-related risk model for predicting prognosis and therapeutic effects of patients with hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37733242 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals upregulated host metabolisms and downregulated immune responses or cell death induced by acute African swine fever virus infection. | Front Vet Sci | 2023 | 37720481 | PubTator, text mining | PubMed |
| Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials. | Front Pharmacol | 2023 | 37719852 | PubTator, text mining | PubMed |
| Diagnostic and prognostic value of autophagy-related key genes in sepsis and potential correlation with immune cell signatures. | Front Cell Dev Biol | 2023 | 37701780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5588/papers?page=5